Table 9.
The correlation of MGMT/hMLH1 promoter methylation with the immunoreaction of the corresponding proteins in all cancers, serrated cancers and their matched controls
MGMT expression* | hMLH1 expression | ||||||||
---|---|---|---|---|---|---|---|---|---|
Promoter methylation of MGMT/hMLH1 | All, N | Positive | Negative | P-value (Fisher's exact test) | All, N | Positive | Negative | P-value (Fisher's exact test) | |
All cases | Unmethylated | 45 | 45 | 0 | <0.0001 | 52 | 48 | 4 | 0.086 |
Unmethylated and methylated | 27 | 21 | 6 | 25 | 21 | 4 | |||
Methylated | 11 | 5 | 6 | 5 | 3 | 2 | |||
Serrated CRC | Unmethylated | 13 | 13 | 0 | 0.041 | 13 | 12 | 1 | 0.186 |
Unmethylated and methylated | 17 | 13 | 4 | 14 | 11 | 3 | |||
Methylated | 4 | 2 | 2 | 4 | 2 | 2 | |||
Matched controls | Unmethylated | 16 | 16 | 0 | 0.013 | 24 | 21 | 3 | 0.553 |
Unmethylated and methylated | 6 | 4 | 2 | 4 | 3 | 1 | |||
Methylated | 6 | 3 | 3 | 1 | 1 | 0 |
For *MGMT immunoreaction, tumour tissue presenting over 10% of positive cells was considered to be positive.
CRC, Colorectal carcinoma.